Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JUNE 03, 2023 SAM #7858
SOLICITATION NOTICE

66 -- MSD Meso Sector S600 Reader and associated components

Notice Date

6/1/2023 3:29:43 PM
 

Notice Type

Presolicitation
 

NAICS

334516 — Analytical Laboratory Instrument Manufacturing
 

Contracting Office

NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
 

ZIP Code

20892
 

Solicitation Number

NOI-NIAID-23-217718
 

Response Due

6/9/2023 2:00:00 PM
 

Archive Date

06/24/2023
 

Point of Contact

Dana Monroe, Phone: 4063759814
 

E-Mail Address

dana.monroe@nih.gov
(dana.monroe@nih.gov)
 

Description

PRE-SOLICITATION NOTICE� ** NOTICE OF INTENT NOI-NIAID-23-2177138 NAICS � 334516, Analytical Laboratory Instrument Mfg This is a Notice of Intent, not a request for proposal.� The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Meso Scale Discovery, a division of Meso Scale Diagnostics, LLC of Rockville, MT to procure a MSD Meso Sector S600 Reader and associated components to be used by the NIH Vaccine Research Center (VRC) Vaccine Immunology Program (VIP) to perform assay testing in support of numerous infectious diseases antibody isolation and development project. The Vaccine Immunology Program (VIP) aids the Vaccine Research Center (VRC) by supporting the development of monoclonal antibodies and vaccines for infectious diseases such as HIV, Influenza, Ebola, and more recently SARS-CoV-2 Coronavirus. Support is through the state-of-the-art laboratory performing Phase 1 and Phase 3 clinical end point testing to inform further study designs, research questions and vaccine modification and design. As the threat of COVID-19 and other respiratory diseases continues in the international community, the need for a safe and efficacious monoclonal antibody therapy at an accelerated timeline is a health care priority. To assist in this effort, the VRC-VIP will use the electrochemiluminescent (ECL) assay format which VIP with Meso Scale Discovery has recently developed for assays for the detection of specific antibodies directed towards SARS CoV-2 S-2P and other respiratory disease glycoproteins. The VRC-VIP identified the ECL assay as the most reliable and sensitive assay system over the last 10 years, that offers high dynamic range in the detection of specific serum antibodies generate towards a variety of viral proteins. The platform offers extremely high throughput for the simultaneous measurement of antibodies to their epitopes. This reader will be used with these proprietary Meso Scale Discovery assays to evaluate and develop new therapeutics. It will be used in conjunction with the Hamilton Vantage automated workstation to perform these functions in high-throughput. MSD are the sole owners of the intellectual property of the ECL reader and associated assays designed in collaboration with VIP specifically for VIP endpoint testing for clinical trials, correlate of protection testing, and screening of therapeutic mAbs. The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.� All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-23-2177138) to Dana Monroe at dana.monroe@nih.gov, by 5:00pm eastern daylight savings time Friday, June 9, 2023. �All responses received by the closing date of this synopsis will be considered by the Government.� A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/35cd6963b7ad45d8ba12299e9b47c973/view)
 

Place of Performance

Address: Gaithersburg, MD 20878, USA

Zip Code: 20878

Country: USA
 

Record

SN06701752-F 20230603/230601230116 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |